fda approval for tirzepatide What Is Used for? Approved and Potential Uses Warning: Risks of Non-FDA Approved

Single target Over 68 weeks Typically mild & temporary Two targets stronger signal ~2022% of body weight Over 72 weeks 1 in 3 lost 25%+ Typically mild & temporary All medications are compounded and medically supervised by Eddie Hughes, FNP-BC

Muscle mass and testosterone are closely linked, and weight loss alone won't protect one without the other

Rezakhaniha, S., Rezakhaniha, B

But whats the difference between KLOW and GLOW

They are also the perfect time to bring up any side effects you might be experiencing

Phosphatidycholine is clinically proven to increase the benefits of Glutathione by enabling absorption and bioavailability